Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 327 of 5804
-
New hope for rare liver disease: drug aims to slow damage
Disease control Not yet recruitingLong-Term Study to Evaluate the Safety and Efficacy in Participants with Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes (EPICS-V)
Phase: PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a daily probiotic prevent iron deficiency in pregnancy?
Prevention Recruiting nowMaternal iron deficiency (ID) and iron deficiency anemia (IDA) is associated with maternal and infant mortality, spontaneous preterm birth, maternal postpartum hemorrhage, and neurocognitive defects in the neonate. Therefore, preventing maternal IDA in at-risk women is critical. …
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Could a brain pacemaker fight Alzheimer's? new trial begins.
Disease control Recruiting nowThe purpose of this study is to test a new procedure to treat Alzheimer's disease. The procedure is called intermittent Deep Brain Stimulation (DBS) of the nucleus basalis of Meynert. There will be up to six participants enrolled at Wellstar MCG Memory Clinic. There will be anoth…
Phase: PHASE1 • Sponsor: Augusta University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can plasma help heal the brain after injury?
Disease control Recruiting nowThe goal of this clinical trial is to learn about treatment with fresh frozen plasma (FFP) in individuals with moderate to severe traumatic brain injury. The two main question\[s\]it aims to answer are: * Is the FFP treatment safe? * Does the FFP treatment impact the 24-hour, 3-…
Phase: PHASE2, PHASE3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New program aims to cut cervical cancer risk in vulnerable women
Prevention Recruiting nowCervical cancer (CC) remains one of the most common malignancies among women in India, with nearly 100,000 women diagnosed annually and over 60,000 preventable deaths annually. With high-risk human papillomavirus (HR-HPV) as the causative agent for CC, one risk factor that places…
Phase: NA • Sponsor: University of California, Irvine • Aim: Prevention
Last updated Jun 28, 2026 00:00 UTC
-
Can cannabis calm War's ghosts? new trial for vets with PTSD
Symptom relief Not yet recruitingThe rationale for the use of inhalational cannabis to potentially treat PTSD symptoms is based on the many reports of cannabis attenuating PTSD symptom expression among individuals with PTSD, including veterans. Study MJP2 is intended to build off MJP-1 through use of a larger sa…
Phase: PHASE2 • Sponsor: Multidisciplinary Association for Psychedelic Studies • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New hope for tough colon cancer: combo therapy targets BRAF mutation
Disease control Not yet recruitingThis is an open-label, single-arm, single-center phase II clinical study, aiming to investigate the safety and efficacy of Aipalolitovorelizumab (QL1706) combined with bevacizumab plus standard chemotherapy regimen as first-line treatment for patients with MSS/pMMR metastatic col…
Phase: PHASE2 • Sponsor: Yanqiao Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a shorter steroid course save preemie lungs?
Prevention Not yet recruitingThe goal of this clinical trial is to compare the effectiveness of two different dexamethasone treatment regimens (the DART regimen and the medium-dose tapering regimen) in reducing the incidence of Bronchopulmonary Dysplasia (BPD) or death by 36 weeks of postmenstrual age in pre…
Phase: PHASE3 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Brain gene therapy aims to boost dopamine in young Parkinson's patients
Disease control Not yet recruitingThis study is looking at whether a gene therapy called AAV2-hAADC is safe and may help people with Parkinson's Disease. AAV2-hAADC is intended to increase the levels of dopamine in your brain. It contains a virus called adeno-associated virus 2 (AAV2) that has been modified to c…
Phase: PHASE1 • Sponsor: Krzysztof Bankiewicz • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Robots vs. laparoscopy: which surgery beats stomach cancer?
Disease control Not yet recruitingThe goal of this multicenter, randomized, phase III clinical trial is to test whether robot-assisted radical gastrectomy improves 3-year recurrence-free survival versus laparoscopy-assisted radical gastrectomy in adults aged 18-80 years with previously untreated, resectable cT4a …
Phase: PHASE3 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo aims to cut transfusions for blood disorder patients
Disease control Recruiting nowβ-thalassemia is one of the most common inherited hemoglobinopathies worldwide and a major public health issue that severely impacts birth quality, human health, and social progress. Currently, there are limited clinical drugs specifically designed to treat patients with β-thalas…
Phase: PHASE2 • Sponsor: Rongrong Liu • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug cocktail aims to shrink cervical tumors before surgery
Disease control Not yet recruitingThis is a phase II, prospective, single-arm, multicenter, open-label study to evaluate the efficacy and safety of sacituzumab tirumotecan in combination with iparomlimab and tuvonralimab as neoadjuvant therapy in patients with locally advanced cervical cancer
Phase: PHASE2 • Sponsor: Zheng Min • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New blood test could boost IVF success for women with repeated failure
Diagnosis Not yet recruitingThe goal of this clinical trial aims to investigate whether a non-invasive implantation window prediction model, constructed based on characteristic changes in peripheral blood miRNAs during the peri-implantation period, can improve pregnancy outcomes in patients with unexplained…
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
New hope: immune drug before surgery for tough colorectal cancer
Disease control Recruiting nowThis study is a prospective, observational, real-world investigation. This study will evaluate the efficacy and safety of tislelizumab monotherapy before surgery in patients with mismatch repair deficient or microsatellite instability high (dMMR/MSI-H) locally advanced colorectal…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Virus turns body into cancer-fighting factory for stubborn lymphoma
Disease control Recruiting nowTo study the safety and effectiveness of oncolytic Vaccinia VIrus-Delivered Targeted CD19 In Vivo CAR-T/M Therapy for Refractory/Relapsed B-Cell Lymphoma
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug cocktail aims to shrink ovarian tumors before surgery
Disease control Not yet recruitingThis study is a prospective, open-label, multicenter Phase II clinical trial, planning to enroll 50 patients with advanced ovarian cancer. Enrolled participants will be assigned to 2 cohorts based on ECOG performance status and genetic mutation status: Cohort 1: ECOG PS 0 or 1, …
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Promising combo may keep rare melanoma at bay
Disease control Recruiting nowMelanoma has emerged as the fastest-growing malignancy in recent years, with incidence and mortality rates among both men and women in East Asian countries exceeding the Asian average. China ranks fifth among East Asian nations in melanoma incidence. Currently, immune checkpoint …
Phase: PHASE2 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for pancreatic cancer: drug combo aims to shrink tumors before surgery
Disease control Not yet recruitingThis study is a Phase II trial evaluating the safety and efficacy of IBI343 in combination with chemotherapy as neoadjuvant therapy for subjects with borderline resectable pancreatic cancer (BRPC). The study enrolls treatment-naïve subjects with CLDN18.2-positive BRPC, confirmed …
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Heart attack survivors: new study seeks safer, smarter drug plan after stents
Disease control Not yet recruiting" Patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES) require optimized medical therapy to prevent recurrent cardiovascular events. This includes both antiplatelet and lipid-lowering strategies. For antip…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New combo attack on metastatic tumors shows promise in early trial
Disease control Not yet recruitingThis open-label, randomized Phase II trial evaluates whether a strategy-based, multimodal local treatment approach improves local control compared with single-modality local therapy in patients with high-burden metastatic disease characterized by multiple metastases and at least …
Phase: PHASE2 • Sponsor: Li Min • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC